Atlas Trials

Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI

Clinical trial NCT06026566 · UNKNOWN

Trial details

NCT number
NCT06026566
Sponsor
Tongji Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
RemimazolamAwake Endotracheal Intubation
Start date
2023-04-01
Primary completion
2025-08-31
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.